All content on this website is provided for educational and research purposes only. It does not constitute medical advice or treatment. This article discusses biological mechanisms also observed in laboratory and preclinical research models, so no clinical efficacy or safety for human use is implied. The substances discussed, which are not registered medicines, are not intended for use in humans or animals.

Matrixyl peptide

Matrixyl is the commercial name for a group of synthetic peptides widely used in cosmetic dermatology and skin care formulations. These peptides are designed to influence biological processes associated with skin repair, collagen production, and extracellular matrix maintenance.

Matrixyl peptide most commonly refers to Palmitoyl Pentapeptide-4, a modified peptide developed for topical use in cosmetic products. It was originally developed by the cosmetic ingredient company Sederma.

Because of its potential effects on skin structure and collagen synthesis, Matrixyl has been studied in research related to anti-aging skin care and dermatological cosmetic science.

Matrixyl peptide is not a pharmaceutical drug but a cosmetic ingredient used in topical skin care products.

How Matrixyl peptide works

Matrixyl peptide belongs to a class of compounds known as signal peptides, which are designed to mimic fragments of naturally occurring proteins involved in tissue repair. Experimental studies suggest that peptides such as Matrixyl may:

  • stimulate collagen synthesis in skin fibroblasts

  • influence production of extracellular matrix proteins, including elastin and glycosaminoglycans

  • support biological processes related to skin repair and regeneration

  • influence signaling pathways involved in dermal structure maintenance

The peptide includes a palmitoyl group, which helps improve its ability to penetrate the outer layers of the skin when used in topical formulations.

Clinical trials and evidence

Research on Matrixyl has been conducted mainly in dermatological and cosmetic science studies examining its effects on skin appearance and structure. Studies have explored:

  • changes in skin wrinkle depth and elasticity

  • stimulation of collagen production in skin cells

  • improvements in certain visible signs of skin aging

Some controlled cosmetic studies have reported improvements in skin texture and reduction in wrinkle appearance following topical use of formulations containing Matrixyl.

However, most research has focused on cosmetic outcomes rather than medical therapeutic applications.

Possible side effects of Matrixyl:

Matrixyl is generally considered well tolerated when used in topical cosmetic formulations. Reported side effects are uncommon but may include:

  • mild skin irritation

  • redness

  • temporary sensitivity in individuals with sensitive skin

These effects are typically mild and localized when they occur.

Matrixyl is a cosmetic peptide ingredient used in topical skin care products and is not approved as a pharmaceutical medication for the treatment of medical conditions. Scientific research involving such compounds should be conducted with appropriate safety precautions and in accordance with applicable laws and regulations in the relevant country.

The purpose of this website is to provide clear, evidence-based information about biologically active compounds often discussed in research, metabolic health, and biohacking communities. The information presented here is educational and should not be considered medical advice.

Matrixyl
Action: Collagen production stimulation | Category: cosmetic peptide
Experimental dosage: 1-2 mg | Frequency: every week | Timing: freely | Cycle on: 4 weeks — Route: subcutaneous (SC). Stop rules: hold and seek medical advice if moderate/severe adverse effects occur (e.g., escalating nausea/vomiting, dizziness, palpitations, significant blood pressure changes, severe injection‑site reactions, allergic symptoms) or if there is no clear ‘return‑to‑baseline’ window between doses. | Cycle off: 4 weeks
Effectiveness: ■■■▢▢ | Safety: ■■■■▢

Related peptides

Peptides from the same functional group:Arg-BPC-157, BPC-157, GHK-Cu, PTD-DBM, TB-500 peptide, Thymosin β4

Our peptides database

5-Amino-1MQ | AICAR peptide | AOD9604 peptide | Arg-BPC-157 peptide | BPC-157 peptide | CagriSema | Cerebrolysin peptide | CJC-1295 NO DAC peptide | CJC-1295 with DAC peptide | Cortagen peptide | Dihexa peptide | DSIP peptide (Delta Sleep-Inducing Peptide) | Dulaglutide peptide | Epithalon peptide | Exenatide peptide | Follistatin 315 peptide | Follistatin 344 peptide | FOXO4-DRI peptide | GHK-Cu peptide | GHRP-2 peptide | GHRP-6 peptide | Hexarelin peptide | HGH Fragment 176-191 | Humanin peptide | IGF-1 LR3 peptide | Ipamorelin CJC-1295 NO DAC | Ipamorelin peptide | Kisspeptin peptide | KPV peptide | L-Carnitine | Liraglutide peptide | Livagen peptide | LL-37 peptide | Matrixyl peptide | Mazdutide peptide | Melanotan II peptide | Melanotan peptide | MGF peptide (Mechano Growth Factor peptide) | MOD GRF 1-29 | MOTS-C peptide | NAD+ coenzime (Nicotinamide Adenine Dinucleotide) | Oxytocin peptide | P21 peptide | PEG-MGF peptide | Pinealon peptide | PT-141 peptide (Bremelanotide) | PTD-DBM peptide | Retatrutide | Selank peptide | Semaglutide | Semax peptide | Sermorelin peptide | SHLP-2 peptide | SHLP-6 peptide | Somatropin peptide | SS-31 peptide (Elamipretide) | TB-500 peptide | Tesamorelin peptide | Thymosin Alpha 1 peptide | Thymosin beta 4 peptide | Thymosin β10 peptide | Thymulin peptide | Tirzepatide | Vilon peptide
Tagged